Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

Keyphrases

• Angiogenesis 100%
• Co-immunoprecipitation (co-IP) 10%
• Conditioned Medium 50%
• Dysregulated 10%
• Dysregulation 10%
• Endothelial Cell Migration 10%
• Endothelial Cells 10%
• Fetal Programming 10%
• Fold Increase 10%
• Hypoxia 20%
• Induced Endothelial Cells 10%
• Inflammatory Disorders 10%
• New Therapeutic Approaches 10%
• Normal Pregnancy 20%
• P Factor 10%
• Placental Angiogenesis 10%
• Placental Explants 10%
• Placental Growth Factor (PlGF) 30%
• Pre-incubation 10%
• Preeclampsia 100%
• Preeclamptic 30%
• Receptor 1 10%
• Relative Ratio 10%
• Serum Levels 10%
• Soluble Fms-like Tyrosine kinase-1 (sFlt-1) 10%
• Soluble Receptor 20%
• Supernatant 10%
• Tissue Normoxia 10%
• Tube Formation 20%
• Tumor Necrosis Factor-α 10%
• Vascular Endothelial Growth Factor 40%
• Vascular Endothelial Growth Factor Receptor (VEGFR) 100%
• Villous Explants 30%

Medicine and Dentistry

• Angiogenesis 100%
• Cell Migration 20%
• Endothelial Cell 40%
• Hypoxia 40%
• Immunoprecipitation 20%
• In Vitro 40%
• Incubation 20%
• Inflammatory Disorder 20%
• Placental Growth Factor 60%
• Pre-Eclampsia 100%
• Receptor 40%
• Tumor Necrosis Factor 20%
• Vasculotropin 80%
• Vasculotropin Receptor 1 100%

Biochemistry, Genetics and Molecular Biology

• Angiogenesis 100%
• Blood Level 20%
• Cell Migration 20%
• Explant 100%
• Immunoprecipitation 20%
• Placental Growth Factor 60%
• Supernatant 20%
• Tumor Necrosis Factor 20%
• Vascular Endothelial Growth Factor 80%
• VEGF Receptors 100%